We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Dims Lights on Three Pipeline Projects, Turns Spotlight on Upcoming Regulatory, Development Milestones
Sanofi Dims Lights on Three Pipeline Projects, Turns Spotlight on Upcoming Regulatory, Development Milestones
January 8, 2013
Sanofi is pulling the plug on three pipeline projects involving multiple sclerosis (MS) drug Aubagio, sarcoma drug ombrabulin and endometrial cancer drug SAR245408.